Maria Whitman

A longtime leader in life sciences, I am dedicated to advancing health. In my current role, I advise on strategy for top pharmaceutical and biotech companies to drive performance and engagement in the ecosystem to improve patient outcomes. Throughout my career in healthcare, I have worked with companies transform their internal and customer-facing organizations; led end to end in marketing strategy, planning and execution; and driven customer-insight based decisions, analytics and digital approaches, value proposition and access, medical affairs, pipeline development, sales and operations, and global and local strategies including launch and market entry. I currently serve on the Board of Directors for ZS. I am a lead in ZS’s Healthcare Leadership Council and Strategy and Advisory team to the CEO. Previously, I led our Practice Council, which focuses on ZS’s leadership in expertise, innovation and collaboration. Before becoming Global Head of Pharmaceuticals and Biotech, I pursued a deep passion: oncology. Leader of ZS’s Oncology Vertical, I worked personally with over 20 companies a year and built a team that supports around 90 percent of all oncology launches today. This led to formation of other core expertise verticals such as cell and gene therapy and sponsoring the advancement of ZS’s work in rare diseases and biosimilars. I’ve had the privilege of sharing my work and expertise with publications including the Wall Street Journal, Pharmaceutical Commerce, Nature, BioSpace, PharmaVoice, Scrip, Pharmacy Times, and more. I currently serve on the Board of Directors for the International Myeloma Foundation (IMF) and the Emergency Aid of Pennsylvania Association.